Скачать или смотреть Preprints and the Scientific Media Landscape - John Inglis

The Genomics and the Media Seminar Series features experts in communicating about genomics across media, including radio, podcasting, writing, speaking, publishing and everything in between. John Inglis, Ph.D., executive director of Cold Spring Harbor Laboratory (CHSL) Press and co-founder of bioRxiv and medRxiv, presents "Preprints and the Scientific Media Landscape." Chris Gunter, Ph.D., senior advisor to the NHGRI director on genomics engagement, moderates the discussion.

#genomicsandthemedia

Chapters:
0:00 - Opening Remarks (Sarah Bates)
3:02 - Introducing John Inglis (Chris Gunter)
4:00 - How did CHSL Press became the big enterprise it is today (John Inglis)
11:19 - What lessons were learned from the authoring the book Davenport's Dream?
15:37 - What review practices were/are in place with the nine CHSL Press-published journals?
18:05 - Will CHSL Press move towards open-access and open-review models?
23:25 - What is a preprint?
24:37 - How was bioRxiv and medRxiv created and what are their futures?
30:14 - Were there times during the setup of bioRxiv and medRxiv, that made you want to give up?
33:02 - If preprints become mainstream, how much of that acceptance is due to insitutional/cultural change of current ecosystem vs. generational change from younger researchers?
36:24 - What is Plan U and what is the long-term funding plan for preprint servers?
41:12 - What would happen to the science media ecosystem if everything was preprinted first?
49:14 - How can we start to move towards plain language summaries of papers? Is this planned as a future option for manuscript submissions?
50:45 - Are there any data related to the fears of being scooped by putting out preprints?
53:41 - Can we expect a culture where preprints are cited along with their peer-reviewed counterparts?
55:40 - How can journalist do a better job of covering or not covering papers posted to bioRxiv?
57:50 - How can preprints be better used to communicate the impact or successes of research initiatives?